|Table of Contents|

Research progress of ultrafast dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of breast cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 04
Page:
770-773
Research Field:
Publishing date:

Info

Title:
Research progress of ultrafast dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of breast cancer
Author(s):
LIU Aoyu; ZHANG Hongxia; ZHANG Lan; ZHANG Xiushi
Harbin Medical University Cancer Hospital,Heilongjiang Harbin 150000,China.
Keywords:
magnetic resonance imaging; benign and malignant breast lesions; breast cancer; ultrafast dynamic contrast-enhanced magnetic resonance imaging
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2024.04.033
Abstract:
Compared with traditional dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI),ultrafast dynamic contrast-enhanced magnetic resonance imaging（UF-DCE MRI）has higher temporal resolution while maintaining reasonable spatial resolution,and can capture the hemodynamic information inside the lesion in the ultra-early period after contrast agent injection.In view of these advantages,UF-DCE MRI technology has been widely used in clinical practice in recent years,and has outstanding performance in the differentiation of benign and malignant breast lesions,prognosis prediction and breast cancer subtype differentiation.Dynamic parameters provided by UF-DCE MRI,such as time to enhancement (TTE),maximum slope (MS) and bolus arrival time（BAT）can not only quantitatively reflect the pathological characteristics of breast lesions,but also have high reproducibility.In addition,compared with conventional DCE-MRI,UF-DCE MRI can more effectively identify rich blood supply lesions when background parenchymal enhancement (BPE) is highly affected.Therefore,this article comprehensively and systematically describes the application and research progress of UF-DCE MRI in the diagnosis of breast lesions,as well as the limitations and future development trends of this technology.

References:

［1］ BRAY F,FERLAY J,SOERJOMATARAM I,et al.GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA:A Cancer Journal for Clinicians,2020,71(2021):209-249.
［2］ SANKATSING VDV,VAN RAVESTEYN NT,HEIJNSDIJK EAM,et al.The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality:20 years of follow-up［J］.International Journal of Cancer,2017,141(4):671-677.
［3］ BROEDERS M,MOSS S,NYSTROM L,et al.The impact of mammographic screening on breast cancer mortality in Europe:a review of observational studies［J］.Journal of Medical Screening,2012,19(1_suppl):14-25.
［4］ MANN RM,MUS RD,VAN ZELST J,et al.A novel approach to contrast-enhanced breast magnetic resonance imaging for screening:high-resolution ultrafast dynamic imaging［J］.Investigative Radiology,2014,49(9):579-585.
［5］ VAN ZELST JCM,VREEMANN S,WITT HJ,et al.Multireader study on the diagnostic accuracy of ultrafast breast magnetic resonance imaging for breast cancer screening［J］.Investigative Radiology,2018,53(10):579-586.
［6］ LEE SJ,KO KH,JUNG HK,et al.The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients［J］.European Journal of Radiology,2020,124:108841.
［7］ MORI N,SHETH D,ABE H.Nonmass enhancement breast lesions:diagnostic performance of kinetic assessment on ultrafast and standard dynamic contrast-enhanced MRI in comparison with morphologic evaluation［J］.American Journal of Roentgenology,2020,215(2):511-518.
［8］ HONDA M,KATAOKA M,IIMA M,et al.Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI［J］.European Journal of Radiology,2020,129:108984.
［9］KUHL CK,MIELCARECK P,KLASCHIK S,et al.Dynamic breast MR imaging:are signal intensity time course data useful for differential diagnosis of enhancing lesions［J］.Radiology,1999,211(1):101-110.
［10］ MUS RD,BORELLI C,BULT P,et al.Time to enhancement derived from ultrafast breast MRI as a novel parameter to discriminate benign from malignant breast lesions［J］.European Journal of Radiology,2017,89:90-96.
［11］ ONISHI N,SADINSKI M,GIBBS P,et al.Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI［J］.European Radiology,2020,30(2):756-766.
［12］ ONISHI N,SADINSKI M,HUGHES MC,et al.Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer［J］.Breast Cancer Research,2020,22(1):1-13.
［13］ CUENOD CA,BALVAY D.Perfusion and vascular permeability:basic concepts and measurement in DCE-CT and DCE-MRI［J］.Diagnostic and Interventional Imaging,2013,94(12):1187-1204.
［14］ PRIES AR,HOPFNER M,LE NOBLE F,et al.The shunt problem:control of functional shunting in normal and tumour vasculature［J］.Nature Reviews Cancer,2010,10(8):587-593.
［15］ JAIN RK.Normalizing tumor microenvironment to treat cancer:bench to bedside to biomarkers［J］.Journal of Clinical Oncology,2013,31(17):2205.
［16］ MUSALL BC,ABDELHAFEZ AH,ADRADA BE,et al.Functional tumor volume by fast dynamic contrast-enhanced MRI for predicting neoadjuvant systemic therapy response in triple-negative breast cancer［J］.Journal of Magnetic Resonance Imaging,2021,54(1):251-260.
［17］KIM JH,PARK VY,SHIN HJ,et al.Ultrafast dynamic contrast-enhanced breast MRI:association with pathologic complete response in neoadjuvant treatment of breast cancer［J］.EurRadiol,2022,32(7):4823-4833.
［18］ RAMTOHUL T,TESCHER C,VAFLARD P,et al.Prospective evaluation of ultrafast breast MRI for predicting pathologic response after neoadjuvant therapies［J］.Radiology,2022,305(3):565-574.
［19］ HONDA M,KATAOKA M,OTA R,et al.Ultrafast DCE MRI for post-NST evaluation of breast cancer［C］.Proceedings of ISMRM & SMRT Annal Meeting,online，2021:142.
［20］杨东鑫.超快速动态增强磁共振 (DCE-MRI) 的定量参数对乳腺病变良恶性的诊断价值及对乳腺癌预后因子的相关性分析［J］.中国医疗器械信息,2019,15:67-68. YANG DX,Value of quantitative parameters of ultra-fast dynamic enhanced magnetic resonance (DCE-MRI) in the diagnosis of benign and malignant breast lesions and correlation analysis of prognostic factors of breast cancer ［J］.China Medical Device Information,2019,15:67-68.
［21］ YAMAGUCHI K,NAKAZONO T,EGASHIRA R,et al.Maximum slope of ultrafast dynamic contrast-enhanced MRI of the breast:Comparisons with prognostic factors of breast cancer［J］.Japanese Journal of Radiology,2021,39(3):246-253.
［22］ GOTO M,SAKAI K,YOKOTA H,et al.Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions［J］.European Radiology,2019,29(3):1164-1174.
［23］ SHIN SU,CHO N,KIM SY,et al.Time-to-enhancement at ultrafast breast DCE-MRI:potential imaging biomarker of tumour aggressiveness［J］.European Radiology,2020,30(7):4058-4068.
［24］ ONISHI N,KATAOKA M.Breast cancer screening for women at high risk:review of current guidelines from leading specialty societies［J］.Breast Cancer,2021,28(6):1195-1211.
［25］ OHASHI A,KATAOKA M,IIMA M,et al.Multiparametric prediction model for triple negative breast cancer subtypes using MR parameters including ultrafast DCE MRI［C］.Proceedings of ISMRM & SMRT Annal Meeting,online,2021:1443.
［26］ MORI N,ABE H,MUGIKURA S,et al.Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma:effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging［J］.Breast Cancer,2021,28(5):1141-1153.
［27］ OHASHI A,KATAOKA M,KANAO S,et al.Diagnostic performance of maximum slope:A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC)［J］.European Journal of Radiology,2019,118:285-292.
［28］ HONDA M,KATAOKA M,ONISHI N,et al.New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing［J］.Journal of Magnetic Resonance Imaging,2020,51(1):164-174.
［29］ DALMIS MU,GUBERN-MERIDA A,VREEMANN S,et al.Artificial intelligence-based classification of breast lesions imaged with a multiparametric breast MRI protocol with ultrafast DCE-MRI,T2,and DWI［J］.Investigative Radiology,2019,54(6):325-332.
［30］ OHASHI A,KATAOKA M,IIMA M,et al.A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI［J］.Magnetic Resonance Imaging,2020,71:154-160.
［31］ ADACHI M,FUJIOKA T,MORI M,et al.Detection and diagnosis of breast cancer using artificial intelligence based assessment of maximum intensity projection dynamic contrast-enhanced magnetic resonance images［J］.Diagnostics,2020,10(5):330.
［32］ FUJIOKA T,YASHIMA Y,OYAMA J,et al.Deep-learning approach with convolutional neural network for classification of maximum intensity projections of dynamic contrast-enhanced breast magnetic resonance imaging［J］.Magnetic Resonance Imaging,2021,75:1-8.
［33］ REIG B,HEACOCK L,GERAS KJ,et al.Machine learning in breast MRI［J］.Journal of Magnetic Resonance Imaging,2020,52(4):998-1018.
［34］ SHETH D,GIGER ML.Artificial intelligence in the interpretation of breast cancer on MRI［J］.Journal of Magnetic Resonance Imaging,2020,51(5):1310-1324.

Memo

Memo:
哈尔滨医科大学附属肿瘤医院海燕基金（编号：JJZD2021-15）
Last Update: 1900-01-01